link.springer.com

Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature - Annals of Hematology

  • ️Petrini, Mario
  • ️Fri Dec 07 2007

  • Van Assche G et al (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s disease. N Engl J Med 353(4):362–368

    Article  PubMed  Google Scholar 

  • Redfearn A et al (1993) Progressive multifocal leukoencephalopathy in a child with immunodeficiency and hyperimmunoglobulinemia M. Pediatr Infect Dis J 12(5):399–401

    Article  PubMed  CAS  Google Scholar 

  • Dorries KA et al (2003) Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals. J Neurovirol 9(Suppl 1):81–87

    Article  PubMed  Google Scholar 

  • Monaco M, Shin J, Major E (1998) JC virus infection in cells from lymphoid tissue. Dev Biol Stand 94:115–22

    PubMed  CAS  Google Scholar 

  • Cervetti G et al (2003) Efficacy and toxicity of liposomila included in PVABEC regime for aggressive NHL of the elderly. Leuk Lymphoma 44(3):465–469

    Article  PubMed  Google Scholar 

  • Caracciolo F et al (1997) Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-VABEC regimen in the treatment of intermediate and high grade non-Hodgkin’s lymphoma of the elderly. Leuk Lymphoma 24(3–4):355–361

    PubMed  CAS  Google Scholar 

  • Khouri I et al (1998) Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 16(12):3803–3809

    PubMed  CAS  Google Scholar 

  • Aversa F et al (2005) Full haplotype—mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 23(15):3447–3754

    Article  PubMed  Google Scholar 

  • Focosi D et al (2006) Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone. Antiviral Res 74(2):156–158

    Article  PubMed  CAS  Google Scholar 

  • Boffil-Mas S, Pina S, Girones R (2000) Documenting the epidemiology patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 66(1):238–245

    Google Scholar 

  • Arthur R et al (1988) BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 158(3):563–569

    PubMed  CAS  Google Scholar 

  • Chan P et al (1994) Association between polyomaviruria and microscopic haematuria in bone marrow transplant recipients. J Infect 29(2):139–146

    Article  PubMed  CAS  Google Scholar 

  • O'Shaughnessy D et al (1994) Grand Rounds–Hammersmith Hospital: clinicopathological conference dizziness and confusion after bone marrow transplantation. BMJ 309(6949):262–265

    PubMed  Google Scholar 

  • Owen R et al (1995) Cytomegalovirus-induced T-cell proliferation and the development of progressive multifocal leucoencephalopathy following bone marrow transplantation. Br J Haematol 89(1):196–198

    PubMed  CAS  Google Scholar 

  • Garcia DDV et al (2002) JC virus load in progressive multifocal leukoencephalopaty: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesion. Clin Infect Dis 34(12):1568–1575

    Article  Google Scholar 

  • Bossolasco S et al (2005) Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 40(5):738–744

    Article  PubMed  CAS  Google Scholar 

  • Pozzo D et al (2006) Conventional and diffusion weighted MRI in progressive multifocal leukoencephalopaty: new elements for identification and follow up. Radiologia Medica 111(7):971–979

    Article  PubMed  Google Scholar 

  • Richardson EJ, Johnson P (1975) Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates. Acta Neuropathol Suppl (Berl) 6:247–250

    Google Scholar 

  • Cinque P, Koralnik I, Clifford D (2003) The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol 9(Suppl 1):88–92

    Article  PubMed  CAS  Google Scholar 

  • Domingo P et al (1997) Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy. Lancet 349(9064):1554–1555

    Article  PubMed  CAS  Google Scholar 

  • Hall CD et al (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 338(19):1345–1351

    Article  PubMed  CAS  Google Scholar 

  • Malkoun I et al (2006) Role of immunity in the development of progressive multifocal leukoencephalopathy: a report of three patients with type B lymphoma and humoral immunodeficiency and six others with acquired immunodeficiency syndrome. Rev Neurol (Paris) 162(1):82–88

    CAS  Google Scholar 

  • Shen X, Tan Y (2001) Detection of oligoclonal immunoglobulins in the cerebrospinal fluid by immunofixation electrophoresis. Clin Chem Lab Med 39(12):1209–1210

    Article  PubMed  CAS  Google Scholar 

  • Sindic C et al (1997) Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy. J Neuroimmunol 76(1–2):100–104

    Article  PubMed  CAS  Google Scholar 

  • Buckanovich R et al (1997) Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy. Ann Hematol 81(7):410–413

    Google Scholar 

  • Coppo P et al (1999) Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Trans 23(4):401–403

    Article  CAS  Google Scholar 

  • Kleinschmidt-DeMasters B, Tyler K (2005) Progressive multifocal leukoencephalopaty complicating treatment with natalizumab and interferon beta 1a for multiple sclerosis. New England J Med 354(4):369–374

    Article  Google Scholar 

  • Blick G et al (1998) Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside. Clin Infect Dis 26(1):191–192

    Article  PubMed  CAS  Google Scholar 

  • Steiger M et al (1993) Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 33(4):407–411

    Article  PubMed  CAS  Google Scholar 

  • Hou J, Major EO (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol 4(4):451–456

    Article  PubMed  CAS  Google Scholar 

  • Rand K et al (1977) Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy. Ann Neurol 1(5):458–462

    Article  PubMed  CAS  Google Scholar 

  • Conomy J et al (1974) Cytarabine treatment of progressive multifocal leukoencephalopathy. Clinical course and detection of virus-like particles after antiviral chemotherapy. JAMA 229(10):1313–1316

    Article  PubMed  CAS  Google Scholar 

  • O'Riordan T et al (1990) Progressive multifocal leukoencephalopathy—remission with cytarabine. J Infect 20(1):51–54

    Article  PubMed  Google Scholar 

  • Steurer M et al (2003) Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 76(2):435–436

    Article  PubMed  Google Scholar 

  • Aksamit A (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 7(4):386–390

    Article  PubMed  CAS  Google Scholar 

  • De Luca A et al (1999) Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 52(4):891–892

    PubMed  Google Scholar 

  • Dodge R (1999) A case study: the use of cidofovir for the management of progressive multifocal leukoencephalopathy. J Assoc Nurses AIDS Care 10(4):70–74

    Article  PubMed  CAS  Google Scholar 

  • Brambilla A et al (1999) Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy. J Neurol 246(8):723–725

    Article  PubMed  CAS  Google Scholar 

  • Viallard J et al (2005) Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 46(11):1659–1662

    Article  PubMed  CAS  Google Scholar 

  • Colosimo C et al (1992) Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy. Acta Neurol Belg 92(1):24–29

    PubMed  CAS  Google Scholar 

  • Elphick GF et al (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306(5700):1380–1383

    Article  PubMed  CAS  Google Scholar 

  • Altschuler E, Kast R (2005) The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Med Hypotheses 65(3):585–586

    Article  PubMed  CAS  Google Scholar 

  • Astrom K, Mancall E, Richardson EJ (1958) Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphocytic leukaemia and Hodgkins disease. Brain 81(1):93–111

    Article  PubMed  CAS  Google Scholar 

  • Gordon H, Bandmann M, Sandbank U (1971) Multiple myeloma associated with progressive multifocal leukoencephalopathy and Pneumocystis carinii pneumonia. Isr J Med Sci 7(4):581–588

    PubMed  CAS  Google Scholar 

  • King J et al (1981) Progressive multifocal leukoencephalopathy. Clin Exp Neurol 17:125–134

    PubMed  CAS  Google Scholar 

  • Ng C, Slavin M, Seymour J (2003) Progressive multifocal leukoencephalopathy complicating Waldenstrom's macroglobulinaemia. Leuk Lymphoma 44(10):1819–1821

    Article  PubMed  Google Scholar 

  • Behar A (1965) Progressive multifocal leukoencephalopathy in a case of acute lymphatic leukemia. Isr J Med Sci 1(4):650–654

    PubMed  CAS  Google Scholar 

  • Ganguly S, Ganguly S, Biswas K (1995) Progressive multifocal leukoencephalopathy in a case of acute lymphocytic leukemia. Indian Pediatr 32(6):684–686

    PubMed  CAS  Google Scholar 

  • Demir E et al (2005) Childhood case of progressive multifocal leukoencephalopathy with improved clinical outcome. J Child Neurol 20(3):241–244

    PubMed  Google Scholar 

  • Garcia-Suarez J et al (2005) Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies. Am J Hematol 80(4):271–281

    Article  PubMed  CAS  Google Scholar 

  • Przepiorka D et al (1997) Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 20(11):983–987

    Article  PubMed  CAS  Google Scholar 

  • Re D et al (1999) Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 23(3):295–298

    Article  PubMed  CAS  Google Scholar 

  • Osorio S et al (2002) Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant 30(12):963–966

    Article  PubMed  CAS  Google Scholar 

  • Goldberg SL et al (2002) Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 99(4):1486–1488

    Article  PubMed  CAS  Google Scholar 

  • Kharfan-Dabaja M et al (2006) Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant 39(4):253–254

    Article  Google Scholar 

  • FDA (2006) FDA warns of safety concern regarding rituxan in new patient population. FDA News

  • Brenchley JM et al (2003) Expression of CD57 defines replicative senescence and antigen-. induced apoptotic death of CD8+ T cells. Blood 101(7):2711–2720

    Article  PubMed  CAS  Google Scholar 

  • Autran B et al (1991) A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 77(10):2237–2241

    PubMed  CAS  Google Scholar 

  • Martin A et al (2004) Results of autologous tranplantation in lymphoma are not improved by increasing the dose ofetoposide in the BEAM regime: a single centre sequential-cohort study. Bone Marrow Transplant 44(3):675–682

    Article  CAS  Google Scholar 

  • Coiffer B (2002) Rituximab in combination with CHOP improves survival in elderly patient with aggressive non Hodgkin’s lymphoma. Sem Oncol 29(2):18–22

    Article  CAS  Google Scholar 

  • Smardova L et al (2005) Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum(plus granulogyte colony-stimulating factor in patient with relapsed Hodgkin’s disease. Leuk Lymphoma 46(7):1017–1022

    Article  PubMed  CAS  Google Scholar